These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11400755)

  • 1. Studies of mass infant screening for Wilson disease by urinary ceruloplasmin.
    Kinoshita Y; Yamakami Y; Mori Y; Haruki E; Kikuchi N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():149-50. PubMed ID: 11400755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson disease in children: analysis of 57 cases.
    Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods.
    Li H; Liu L; Li Y; He S; Liu Y; Li J; Tao R; Li W; Shang S
    Medicine (Baltimore); 2018 Jul; 97(27):e11405. PubMed ID: 29979436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective determination of ceruloplasmin in newborn screening blood spots of patients with Wilson disease.
    Kroll CA; Ferber MJ; Dawson BD; Jacobson RM; Mensink KA; Lorey F; Sherwin J; Cunningham G; Rinaldo P; Matern D; Hahn SH
    Mol Genet Metab; 2006; 89(1-2):134-8. PubMed ID: 16644258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.
    Nicastro E; Ranucci G; Vajro P; Vegnente A; Iorio R
    Hepatology; 2010 Dec; 52(6):1948-56. PubMed ID: 20967755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass screening for Wilson's disease by measuring urinary holoceruloplasmin.
    Owada M; Suzuki K; Fukushi M; Yamauchi K; Kitagawa T
    J Pediatr; 2002 May; 140(5):614-6. PubMed ID: 12032531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and presymptomatic detection of Wilson's disease at the mandatory 3-year-old medical health care examination in Hokkaido Prefecture with the use of a novel automated urinary ceruloplasmin assay.
    Nakayama K; Kubota M; Katoh Y; Sawada Y; Saito A; Nishimura K; Katsura E; Ichihara N; Suzuki T; Kouguchi H; Tamura M; Honma H; Kanzaki S; Itami H; Ohtake A; Kobayashi K; Ariga T; Fujieda K; Shimizu N; Aoki T
    Mol Genet Metab; 2008 Jul; 94(3):363-7. PubMed ID: 18424137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
    Foruny JR; Boixeda D; López-Sanroman A; Vázquez-Sequeiros E; Villafruela M; Vázquez-Romero M; Rodríguez-Gandía M; de Argila CM; Camarero C; Milicua JM
    Scand J Gastroenterol; 2008; 43(5):597-603. PubMed ID: 18415754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference intervals of spot urine copper excretion in preschool children and potential application in pre-symptomatic screening of Wilson disease.
    Tang NL; Hui J; Huang D; Tang MF; Wang X; Wu J; Chan IHS; Leung TF
    Pathology; 2020 Jun; 52(4):439-446. PubMed ID: 32276787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct measurement of free copper in serum or plasma ultrafiltrate.
    McMillin GA; Travis JJ; Hunt JW
    Am J Clin Pathol; 2009 Feb; 131(2):160-5. PubMed ID: 19141375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of mass screening for Wilson's disease in Korea.
    Hahn SH; Lee SY; Jang YJ; Kim SN; Shin HC; Park SY; Han HS; Yu ES; Yoo HW; Lee JS; Chung CS; Lee SY; Lee DH
    Mol Genet Metab; 2002 Jun; 76(2):133-6. PubMed ID: 12083810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoenzyme determination of total serum ceruloplasmin. Application to Wilson disease.
    Saenko EL; Skorobogatko OV; Yaropolov AI
    Biochem Int; 1991 Mar; 23(5):819-24. PubMed ID: 1883396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation.
    Yoshitoshi EY; Takada Y; Oike F; Sakamoto S; Ogawa K; Kanazawa H; Ogura Y; Okamoto S; Haga H; Ueda M; Egawa H; Kasahara M; Tanaka K; Uemoto S
    Transplantation; 2009 Jan; 87(2):261-7. PubMed ID: 19155982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators.
    Squitti R; Ghidoni R; Simonelli I; Ivanova ID; Colabufo NA; Zuin M; Benussi L; Binetti G; Cassetta E; Rongioletti M; Siotto M
    J Trace Elem Med Biol; 2018 Jan; 45():181-188. PubMed ID: 29173477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Different Diagnostic Test for Identifying Wilson's Disease.
    Sonia ZF; Rukunuzzaman M; Karim MB; Yasmin A; Alam R
    Mymensingh Med J; 2022 Jan; 31(1):117-123. PubMed ID: 34999690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is low serum tocopherol in Wilson's disease a significant symptom?
    Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB
    J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of screening for Wilson disease using dried blood spots obtained from children seen at outpatient clinics.
    Ohura T; Abukawa D; Shiraishi H; Yamaguchi A; Arashima S; Hiyamuta S; Tada K; Iinuma K
    J Inherit Metab Dis; 1999 Feb; 22(1):74-80. PubMed ID: 10070620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic transplantation in Wilson disease.
    Groth CG; Dubois RS; Corman J; Halgrimson C; Rodgerson DO; Starzl TE
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):106-8. PubMed ID: 4611521
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and Serum Creatinine Can Differentiate Wilson Disease Patients with Pseudonormal Ceruloplasmin.
    Chen L; Shi Y; Wang N; Lou Z; Pan L; Xu X; Wu C; Han Y; Yang R; Hu W; Ruan B
    Int J Clin Pract; 2023; 2023():9344891. PubMed ID: 36915635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.